[1]
Shah, B., Nagar, N. and Nagar, S.S. 2017. A comparative study of maternal & neonatal outcome and patient satisfaction with intravaginal misoprostol versus intravenous oxytocin in patients with premature rupture of membranes beyond 36 weeks gestation. International Journal of Basic & Clinical Pharmacology. 2, 3 (Jan. 2017), 315–319.